CS221831B2 - Method of preparation of the anti-inflammation steroid mixture of the type 9-chlore-11beta,17,21-trihydroxy-16beta-methyl-1,4-pregnadine-3,20-dion17,21-dipropionate pulverised on the size of particles mlesser than 5 min and fluorchlor-hydrocarbon utilized as actuating substace - Google Patents
Method of preparation of the anti-inflammation steroid mixture of the type 9-chlore-11beta,17,21-trihydroxy-16beta-methyl-1,4-pregnadine-3,20-dion17,21-dipropionate pulverised on the size of particles mlesser than 5 min and fluorchlor-hydrocarbon utilized as actuating substace Download PDFInfo
- Publication number
- CS221831B2 CS221831B2 CS813676A CS367681A CS221831B2 CS 221831 B2 CS221831 B2 CS 221831B2 CS 813676 A CS813676 A CS 813676A CS 367681 A CS367681 A CS 367681A CS 221831 B2 CS221831 B2 CS 221831B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- propellant
- steroid
- particles
- dipropionate
- particle size
- Prior art date
Links
- 239000002245 particle Substances 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 14
- 150000003431 steroids Chemical class 0.000 title claims abstract description 10
- 239000000203 mixture Substances 0.000 title claims description 19
- 238000002360 preparation method Methods 0.000 title claims description 5
- 239000004215 Carbon black (E152) Substances 0.000 title description 2
- 206010061218 Inflammation Diseases 0.000 title 1
- 239000003380 propellant Substances 0.000 claims abstract description 18
- 239000000725 suspension Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims abstract 2
- 238000003756 stirring Methods 0.000 claims description 9
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims description 6
- 229940029284 trichlorofluoromethane Drugs 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 4
- 239000004338 Dichlorodifluoromethane Substances 0.000 claims description 3
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 3
- 235000019404 dichlorodifluoromethane Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 abstract description 3
- 239000013078 crystal Substances 0.000 description 11
- 238000004090 dissolution Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- BOSAWIQFTJIYIS-UHFFFAOYSA-N 1,1,1-trichloro-2,2,2-trifluoroethane Chemical compound FC(F)(F)C(Cl)(Cl)Cl BOSAWIQFTJIYIS-UHFFFAOYSA-N 0.000 description 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 241000287127 Passeridae Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229950000210 beclometasone dipropionate Drugs 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
- C09K3/30—Materials not provided for elsewhere for aerosols
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI801610A FI63672C (fi) | 1980-05-19 | 1980-05-19 | Foerfarande foer framstaellning av en blandning av beklometasondipropionat och triklorfluormetan eller diklordifluormetan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS221831B2 true CS221831B2 (en) | 1983-04-29 |
Family
ID=8513487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS813676A CS221831B2 (en) | 1980-05-19 | 1981-05-18 | Method of preparation of the anti-inflammation steroid mixture of the type 9-chlore-11beta,17,21-trihydroxy-16beta-methyl-1,4-pregnadine-3,20-dion17,21-dipropionate pulverised on the size of particles mlesser than 5 min and fluorchlor-hydrocarbon utilized as actuating substace |
Country Status (21)
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR890000664B1 (ko) * | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
| DE3767615D1 (de) * | 1986-03-10 | 1991-02-28 | Kurt Burghart | Pharmazeutikum sowie verfahren zu seiner herstellung. |
| JPH01156916A (ja) * | 1987-09-25 | 1989-06-20 | Ss Pharmaceut Co Ltd | 肝疾患治療剤 |
| US5658549A (en) * | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
| US5916540A (en) * | 1994-10-24 | 1999-06-29 | Glaxo Group Limited | Aerosol formulations containing P134A and/or P227 and particulate medicament |
| US5736124A (en) * | 1991-12-12 | 1998-04-07 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
| WO1993011744A1 (en) * | 1991-12-12 | 1993-06-24 | Glaxo Group Limited | Medicaments |
| IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
| US5674471A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Aerosol formulations containing P134a and salbutamol |
| US5744123A (en) * | 1991-12-12 | 1998-04-28 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
| US5653962A (en) * | 1991-12-12 | 1997-08-05 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
| US7105152B1 (en) | 1991-12-18 | 2006-09-12 | 3M Innovative Properties Company | Suspension aerosol formulations |
| ES2159678T3 (es) | 1991-12-18 | 2001-10-16 | Minnesota Mining & Mfg | Formulaciones de aerosol en suspension. |
| US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
| GB9202519D0 (en) * | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
| US5376359A (en) * | 1992-07-07 | 1994-12-27 | Glaxo, Inc. | Method of stabilizing aerosol formulations |
| MX9304585A (es) * | 1992-07-31 | 1994-03-31 | Glaxo Group Ltd | Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata. |
| GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
| US7582284B2 (en) | 2002-04-17 | 2009-09-01 | Nektar Therapeutics | Particulate materials |
| ES2691033T3 (es) | 2007-02-11 | 2018-11-23 | Map Pharmaceuticals Inc. | Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios |
| CA2895816C (en) | 2012-12-21 | 2021-02-23 | Map Pharmaceuticals, Inc. | 8'-hydroxy-dihydroergotamine compounds and compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE629985A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1962-11-29 | |||
| GB1429184A (en) * | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
| JPS531814A (en) * | 1976-06-28 | 1978-01-10 | Toshiba Corp | Control unit of induction motor |
| US4225597A (en) * | 1976-10-01 | 1980-09-30 | Schering Corporation | Beclomethasone dipropionate-hexane solvate and aerosols prepared therefrom |
| IT1121513B (it) * | 1979-05-28 | 1986-04-02 | Chiesi Farma Spa | Processo per la conversione di umo steroide antiinfiammatorio in una forma suscettibile di essere somministarta come aerosol |
-
1980
- 1980-05-19 FI FI801610A patent/FI63672C/fi not_active IP Right Cessation
-
1981
- 1981-04-21 AT AT0179181A patent/AT380791B/de not_active IP Right Cessation
- 1981-04-24 GB GB8112683A patent/GB2076422B/en not_active Expired
- 1981-04-29 CA CA000376540A patent/CA1162852A/en not_active Expired
- 1981-05-06 PT PT72989A patent/PT72989B/pt unknown
- 1981-05-15 CH CH3165/81A patent/CH647408A5/de not_active IP Right Cessation
- 1981-05-15 BE BE0/204802A patent/BE888822A/fr unknown
- 1981-05-15 FR FR8109719A patent/FR2482457A1/fr active Granted
- 1981-05-18 DE DE19813119745 patent/DE3119745A1/de not_active Withdrawn
- 1981-05-18 SU SU813283353A patent/SU1184428A3/ru active
- 1981-05-18 DD DD81230036A patent/DD158856A5/de unknown
- 1981-05-18 NO NO811686A patent/NO155429C/no unknown
- 1981-05-18 PL PL1981231220A patent/PL127872B1/pl unknown
- 1981-05-18 DK DK218481A patent/DK218481A/da not_active Application Discontinuation
- 1981-05-18 ES ES502286A patent/ES8203606A1/es not_active Expired
- 1981-05-18 CS CS813676A patent/CS221831B2/cs unknown
- 1981-05-18 HU HU811405A patent/HU188093B/hu unknown
- 1981-05-19 US US06/265,333 patent/US4347236A/en not_active Expired - Fee Related
- 1981-05-19 SE SE8103143A patent/SE437766B/sv not_active IP Right Cessation
- 1981-05-19 NL NL8102457A patent/NL8102457A/nl not_active Application Discontinuation
- 1981-05-19 JP JP7433181A patent/JPS5716820A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BE888822A (fr) | 1981-11-16 |
| CA1162852A (en) | 1984-02-28 |
| FI63672C (fi) | 1983-08-10 |
| DE3119745A1 (de) | 1982-02-11 |
| FR2482457A1 (fr) | 1981-11-20 |
| SE8103143L (sv) | 1981-11-20 |
| FI63672B (fi) | 1983-04-29 |
| FR2482457B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1985-01-04 |
| ES502286A0 (es) | 1982-04-01 |
| NO155429B (no) | 1986-12-22 |
| ES8203606A1 (es) | 1982-04-01 |
| ATA179181A (de) | 1985-12-15 |
| CH647408A5 (de) | 1985-01-31 |
| JPS5716820A (en) | 1982-01-28 |
| FI801610A7 (fi) | 1981-11-20 |
| PL231220A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1982-01-18 |
| NL8102457A (nl) | 1981-12-16 |
| GB2076422B (en) | 1983-12-14 |
| NO155429C (no) | 1987-04-01 |
| PL127872B1 (en) | 1983-12-31 |
| DD158856A5 (de) | 1983-02-09 |
| HU188093B (en) | 1986-03-28 |
| US4347236A (en) | 1982-08-31 |
| PT72989A (en) | 1981-06-01 |
| AT380791B (de) | 1986-07-10 |
| SU1184428A3 (ru) | 1985-10-07 |
| SE437766B (sv) | 1985-03-18 |
| DK218481A (da) | 1981-11-20 |
| PT72989B (en) | 1983-07-06 |
| GB2076422A (en) | 1981-12-02 |
| NO811686L (no) | 1981-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS221831B2 (en) | Method of preparation of the anti-inflammation steroid mixture of the type 9-chlore-11beta,17,21-trihydroxy-16beta-methyl-1,4-pregnadine-3,20-dion17,21-dipropionate pulverised on the size of particles mlesser than 5 min and fluorchlor-hydrocarbon utilized as actuating substace | |
| AU587010B2 (en) | Physically modified beclomethasone dipropionate suitable for use in aerosols | |
| RU2294737C2 (ru) | Медицинские аэрозольные составы | |
| US4364923A (en) | Chemical compounds | |
| EP0536204B1 (en) | The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations | |
| DE2703119C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| CA1075228A (en) | Flunisolide to treat respiratory diseases | |
| EP0162556B1 (en) | Novels forms and formulations of nedocromil sodium | |
| EP0039369A1 (en) | Beclomethasone ester solvates, process for their preparation, and preparation of a formulation | |
| EP0260241A1 (en) | A new system for administration of liposomes to mammals | |
| KR950006917B1 (ko) | 수성 유동성 살충제 농축 조성물 | |
| CZ20012217A3 (cs) | Farmaceutické aerosolové přípravky obsahující fluoralkany a budesonid | |
| US4913892A (en) | Preparation and use of new solvates of beclomethasone 17,21-dipropionate | |
| US4225597A (en) | Beclomethasone dipropionate-hexane solvate and aerosols prepared therefrom | |
| AU645366B2 (en) | Aerosol composition and a process preparing same | |
| US20160271145A1 (en) | Method for enlarging the particle size of crystalline microparticles of active substance | |
| NZ187894A (en) | Pressure pack formulations of lecithin or a sorbitan or sorbitol ester | |
| CA1176171A (en) | Compositions containing the disodium salt of 1,3- bis(2-carboxychromon-5-yloxy)-propan-2-ol | |
| GB2196254A (en) | Nedocromil sodium formation | |
| HU180348B (hu) | Eljárás beklometazon-észter-szolvátok előállítására | |
| JPH03178990A (ja) | クロロフルオロカーボンを基剤とした微細結晶計量エアゾールでの使用に適する特別の結晶性向を示すジプロピオン酸ベクロメタゾンの製造方法 | |
| JPH0129199B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DD299211A7 (de) | Verfahren zur herstellung einer aerosolformulierung |